TH148303B - Deficient B. texasporus cells in spore formation. And an efficient and cost-effective method For inactivity and its use - Google Patents

Deficient B. texasporus cells in spore formation. And an efficient and cost-effective method For inactivity and its use

Info

Publication number
TH148303B
TH148303B TH1301004739A TH1301004739A TH148303B TH 148303 B TH148303 B TH 148303B TH 1301004739 A TH1301004739 A TH 1301004739A TH 1301004739 A TH1301004739 A TH 1301004739A TH 148303 B TH148303 B TH 148303B
Authority
TH
Thailand
Prior art keywords
deficient
spore formation
inactivity
efficient
cost
Prior art date
Application number
TH1301004739A
Other languages
Thai (th)
Other versions
TH1301004739A (en
Inventor
เจียง อี้เหว่ย
Original Assignee
มายแกแล็กซี่ ลิมิเต็ด คอมพานี
Filing date
Publication date
Publication of TH1301004739A publication Critical patent/TH1301004739A/en
Application filed by มายแกแล็กซี่ ลิมิเต็ด คอมพานี filed Critical มายแกแล็กซี่ ลิมิเต็ด คอมพานี
Publication of TH148303B publication Critical patent/TH148303B/en

Links

Abstract

สารเชื้อเเบบใหม่ เเละวิธีการสำหรับการใช้งานของมันได้ถูกจัดหามา โดยเฉพาะว่า อาหารเเละ ผลิตภัณฑ์ทางปากอื่น หรือการบำบัดซึ่งมีสายเชื้อ Brevibacilus ที่บกพร่องในการเกิดสปอร์อยู่ เมื่อถูก บำรุงเข้าสู่สัตว์ทดลอง สามารถตยับยั้งหรือลดจำนวนของเชื้อโรคในสัตว์ทดลอง เเละปรับปรุงสุขภาพ ของสัตว์ทดลอง New substances And methods for their use are specifically provided as food and other oral products. Or therapy in which strains of Brevibacilus deficient in spore formation exist when fed into laboratory animals Can inhibit or reduce the number of pathogens in laboratory animals. And improve health Of laboratory animals

Claims (1)

1.สายเชื้อ B.texasporus ที่บกพร่องในการเกิดสปอร์ ซึ่งเสดงอัตราการอยู่รอดน้อยกว่า ประมาณ 3.5 x 103 เมื่อทำการเผยออกสู่อุณหภูมิประมาณ 50 องศาเซลเซียส เป็นเวลาประมาณ 5 นาที เเละทำการวัดอัตราการอยู่รอด1. B.texasporus strains deficient in spore formation The survival rate was less than approximately 3.5 x 103 when exposure was approximately 50 ° C for approximately 5 minutes and the survival rate was measured.
TH1301004739A 2012-02-28 Deficient B. texasporus cells in spore formation. And an efficient and cost-effective method For inactivity and its use TH148303B (en)

Publications (2)

Publication Number Publication Date
TH1301004739A TH1301004739A (en)
TH148303B true TH148303B (en) 2016-04-01

Family

ID=

Similar Documents

Publication Publication Date Title
HK1223628A1 (en) The use of novel 7-ketone-6-alkylcholanic acid derivative in preparation of obeticholic acid, and the use thereof in medical field 7--6-
EA201792547A1 (en) BACTERIA POPULATIONS FOR STIMULATING HEALTH CONDITION
IL231536A (en) Indazole-3-carboxamides , pharmaceutical compositions comprising them and their use in the treatment of diseases
PH12015502216A1 (en) Compositions and methods for improving the health of aquatic animals
WO2014153194A3 (en) Methods for pathogen detection and enrichment from materials and compositions
NZ628294A (en) Compositions and methods of use of phorbol esters for the treatment of stroke
HK1202415A1 (en) Pharmaceutical compositions comprising dgla, 15-ohepa, and/or 15- hetre and methods of use thereof dgla15-ohepa/ 15-hetre
UA112068C2 (en) GEL COMPOSITION
PL2925147T3 (en) Composition comprising paecilomyces lilacinus strain 251 and pencycuron
DK2809168T3 (en) MULTI-LAYER MICRO-ENVELOPED PROBIOTIC BACTERIA AND FOOD AND PHARMACEUTICAL COMPOSITIONS INCLUDING MENTIONED BACTERIA
SI2771329T1 (en) Novel disubstituted 3,4-diamino-3-cyclobutene-1,2-dione compounds for use in the treatment of chemokine-mediated diseases
WO2015153772A3 (en) Zirconium-89 oxine complex as a cell labeling agent for positron emission tomography
EP2710116A4 (en) Avirulent modified salmonella gallinarum strains and pharmaceutical composition using the same
EP2773317A4 (en) Compositions for improving the oral health of animals, methods using the same, and pet treats incorporating the same
EA201401117A1 (en) COMPOSITIONS CONTAINING PROBIOTICS AND COMPLEX OF BEE POULTRY / CLAY, METHOD OF THEIR PREPARATION AND THEIR APPLICATION IN FOOD AND THERAPY
PL3260865T3 (en) Method for the treatment of blood, blood products and organs
EP2706863A4 (en) Fat compositions and related methods, including shortening particles and shortening compositions without added non-interesterified hardstock fat, and related products
PH12017500018A1 (en) Myo-inositol and probiotics, and their use
GB2515440B (en) Vesicular Formulations for use in the treatment of Rosacea
MX351862B (en) Compositions and methods for lowering counts of pathogenic microorganisms in food products.
EP2659786A4 (en) Probiotic food suitable for salmonid fish species and the preparation thereof
FR2994634B1 (en) FRESH SPIRULINA FOOD COMPOSITION AND PROCESS FOR PREPARING THE SAME
TH148303B (en) Deficient B. texasporus cells in spore formation. And an efficient and cost-effective method For inactivity and its use
MX2013012551A (en) Use of 3-carboxy-n-ethyl-n,n-dimethylpropan-1-aminium salts in the treatment of cardiovascular disease.
PL2862576T3 (en) Microorganisms and compositions comprising them for use in the treatment or prevention of mastitis